Abstract
Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCNGuidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.
Cite
CITATION STYLE
Davies, K., Barth, M., Armenian, S., Audino, A. N., Barnette, P., Cuglievan, B., … Freedman-Cass, D. A. (2020, August 1). Pediatric aggressive mature b-cell lymphomas, version 2.2020. JNCCN Journal of the National Comprehensive Cancer Network. Harborside Press. https://doi.org/10.6004/jnccn.2020.0036
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.